首页> 美国卫生研究院文献>PLoS Clinical Trials >Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial

【2h】

Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial

机译：铋，奥美拉唑，甲硝唑联合阿莫西林或四环素作为一线治疗根除十二指肠溃疡幽门螺杆菌的一线治疗的疗效和耐受性：一项随机临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimTo evaluate the efficacy and tolerability of tetracycline vs. high-dose amoxicillin in bismuth-based quadruple therapy for Helicobacter pylori(H. pylori) eradication.

机译：目的评估四环素与大剂量阿莫西林在基于铋的四联疗法中根除幽门螺杆菌（H. pylori）的疗效和耐受性。

著录项

期刊名称 PLoS Clinical Trials
作者
Hassan Salmanroghani; Massoud Mirvakili; Mahmud Baghbanian; Roham Salmanroghani; Golshid Sanati; Pouria Yazdian;
展开▼
作者单位

展开▼
年(卷),期 2012(13),6
年度 2012
页码 e0197096
总页数 11
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial [J] . Xie Yong, Pan Xiaolin, Li Yan, The Journal of Antimicrobial Chemotherapy . 2018,第6期

机译：新的单粒溶质，甲硝唑和四环素与奥美拉唑与四人疗法组成，由铋，奥美拉唑，阿莫西林和克拉霉素消除十二指肠溃疡患者的幽门螺杆菌：中国未来，随机，多期面试验
2. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial [J] . Fariborz Mansour-Ghanaei, Alireza Samadi, Farahnaz Joukar, EXCLI Journal . 2019,第3期

机译：14天顺序四肢细胞疗法的疗效和耐受性：泮托拉唑，铋，阿莫西林，甲硝唑和呋喃唑酮作为一种消除幽门螺杆菌的一线治疗：随机，双盲临床试验
3. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori : a prospective, multi-center, randomized clinical trial [J] . Ju Yup Lee, Nayoung Kim, Kyung Sik Park, BMC Gastroenterology . 2016,第1期

机译：序贯治疗与含阿莫西林/四环素铋四联疗法一线根除幽门螺杆菌的比较：一项前瞻性，多中心，随机临床试验
4. Development of a novel intragastric controlled release delivery system for simultaneous delivery of metronidazole, tetracycline hydrochloride, colloidal bismuth subcitrate and an H2 receptor antagonist: Used in eradication of Helicobacter pylori associated ulcer. [D] . Wu, Yunqi. 2004

机译：新型胃内控释输送系统的开发，用于同时输送甲硝唑，四环素盐酸盐，胶体次柠檬酸铋和H2受体拮抗剂：用于根除幽门螺杆菌相关溃疡。
5. Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole bismuth amoxicillin metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized double-blind clinical trial [O] . Fariborz Mansour-Ghanaei, Alireza Samadi, Farahnaz Joukar, 2019

机译：十四天连续四次方案：pan托拉唑铋阿莫西林甲硝唑和/或呋喃唑酮作为根除幽门螺杆菌的一线治疗的疗效和耐受性：一项随机双盲临床试验
6. Efficacy of two-week quadruple bismuth treatment versus levofloxacin concomitant Helicobacter Pylori infection regimen as empirical first-line therapy Syrian patients. A randomized controlled trial. [O] . Marouf Muhammad Alhalabi, Mohammed Waleed Alassi, Kamal Alaa Eddin, 2020

机译：两周四重铋治疗的功效与左氧氟沙星伴随幽门螺杆菌感染方案作为经验一线治疗叙利亚患者。随机对照试验。

Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅